695 related articles for article (PubMed ID: 27009115)
21. Brain-gut axis: from basic understanding to treatment of IBS and related disorders.
Camilleri M; Di Lorenzo C
J Pediatr Gastroenterol Nutr; 2012 Apr; 54(4):446-53. PubMed ID: 22027566
[TBL] [Abstract][Full Text] [Related]
22. Irritable Bowel Syndrome, Depression, and Neurodegeneration: A Bidirectional Communication from Gut to Brain.
Aziz MNM; Kumar J; Muhammad Nawawi KN; Raja Ali RA; Mokhtar NM
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578939
[TBL] [Abstract][Full Text] [Related]
23. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms.
Elsenbruch S
Brain Behav Immun; 2011 Mar; 25(3):386-94. PubMed ID: 21094682
[TBL] [Abstract][Full Text] [Related]
24. The Place of Stress and Emotions in the Irritable Bowel Syndrome.
Pellissier S; Bonaz B
Vitam Horm; 2017; 103():327-354. PubMed ID: 28061975
[TBL] [Abstract][Full Text] [Related]
25. The gut microbiome and irritable bowel syndrome: State of art review.
Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
[TBL] [Abstract][Full Text] [Related]
26. Rationale for using serotonergic agents to treat irritable bowel syndrome.
Baker DE
Am J Health Syst Pharm; 2005 Apr; 62(7):700-11; quiz 712-3. PubMed ID: 15790796
[TBL] [Abstract][Full Text] [Related]
27. [Irritable Bowel Syndrome; gut microbiota and probiotic therapy].
Tojo González R; Suarez Gonzalez A; Rúas Madiedo P; Mancebo Mata A; Pipa Muñiz M; Barreiro Alonso E; Roman Llorente FJ; Moro Villar MC; Arce González MM; Villegas Diaz MF; Mosquera Sierra E; Ruiz Ruiz M
Nutr Hosp; 2015 Feb; 31 Suppl 1():83-8. PubMed ID: 25659060
[TBL] [Abstract][Full Text] [Related]
28. Uncovering the pathophysiology of irritable bowel syndrome by exploring the gut-brain axis: a narrative review.
Tang HY; Jiang AJ; Wang XY; Wang H; Guan YY; Li F; Shen GM
Ann Transl Med; 2021 Jul; 9(14):1187. PubMed ID: 34430628
[TBL] [Abstract][Full Text] [Related]
29. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
[TBL] [Abstract][Full Text] [Related]
30. Visceral hypersensitivity in irritable bowel syndrome.
Kanazawa M; Hongo M; Fukudo S
J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
[TBL] [Abstract][Full Text] [Related]
31. [Irritable Bowel Syndrome, Emotion Regulation, and Gut Microbiota].
Fukudo S
Brain Nerve; 2016 Jun; 68(6):607-15. PubMed ID: 27279158
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of Stress-Induced Visceral Pain: Implications in Irritable Bowel Syndrome.
Greenwood-Van Meerveld B; Moloney RD; Johnson AC; Vicario M
J Neuroendocrinol; 2016 Aug; 28(8):. PubMed ID: 26749172
[TBL] [Abstract][Full Text] [Related]
33. [Psychosocial factors and visceral hypersensitivity in irritable bowel syndrome].
Lee OY
Korean J Gastroenterol; 2006 Feb; 47(2):111-9. PubMed ID: 16498276
[TBL] [Abstract][Full Text] [Related]
34. Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome.
Chen M; Ruan G; Chen L; Ying S; Li G; Xu F; Xiao Z; Tian Y; Lv L; Ping Y; Cheng Y; Wei Y
Front Endocrinol (Lausanne); 2022; 13():817100. PubMed ID: 35250873
[TBL] [Abstract][Full Text] [Related]
35. Maternal separation as a model of brain-gut axis dysfunction.
O'Mahony SM; Hyland NP; Dinan TG; Cryan JF
Psychopharmacology (Berl); 2011 Mar; 214(1):71-88. PubMed ID: 20886335
[TBL] [Abstract][Full Text] [Related]
36. Sex as a biological variable in irritable bowel syndrome.
Camilleri M
Neurogastroenterol Motil; 2020 Jul; 32(7):e13802. PubMed ID: 31943595
[TBL] [Abstract][Full Text] [Related]
37. Irritable bowel syndrome: new findings in pathophysiological and therapeutic field.
Catanzaro R; Occhipinti S; Calabrese F; Anzalone MG; Milazzo M; Italia A; Marotta F
Minerva Gastroenterol Dietol; 2014 Jun; 60(2):151-63. PubMed ID: 24780949
[TBL] [Abstract][Full Text] [Related]
38. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
Harris LA; Baffy N
Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
[TBL] [Abstract][Full Text] [Related]
39. Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia.
Daulatzai MA
Neurochem Res; 2014 Apr; 39(4):624-44. PubMed ID: 24590859
[TBL] [Abstract][Full Text] [Related]
40. Irritable bowel syndrome: recent and novel therapeutic approaches.
Andresen V; Camilleri M
Drugs; 2006; 66(8):1073-88. PubMed ID: 16789793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
